Financials Jaguar Health, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 23/04/2026 am IST			5-day change	1st Jan Change
0.4098 ^USD	+0.81%		-4.39%	-55.99%

10/04	Jaguar Health, Inc., Q4 2025 Earnings Call, Apr 10, 2026
07/04	Jaguar Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	4.335	11.96	-	11.69	11.51	20.46	14.11
Change	-	175.8%	-	-	-1.52%	77.78%	-31.03%
EBITDA ¹	-	-	-	-	-44	4.157	-0.586
Change	-	-	-	-	-	109.45%	-114.1%
EBIT ¹	-40.71	-34.42	-	-30.83	-45.91	2.264	-2.477
Change	-	15.46%	-	-	-48.9%	104.93%	-209.41%
Interest Paid	-8.421	-12.72	-	-0.231	-	-	-
Earnings before Tax (EBT) ¹	-52.6	-48.4	-	-39.25	-54	-2.436	-6.077
Change	-	7.99%	-	-	-37.57%	95.49%	-149.47%
Net income ¹	-52.6	-47.45	-41.3	-38.49	-53.58	-1.876	-5.517
Change	-	9.77%	12.97%	6.8%	-39.18%	96.5%	-194.08%
Announcement Date	11/03/22	24/03/23	01/04/24	31/03/25	07/04/26	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3
Net sales ¹	1.241	0.385	0.63	2.08	2.625	2.921	3.15	3.26	-	2.676	2.813	2.351	2.721	3.066	3.509	2.214	2.979	3.083
Change	-	-68.98%	63.64%	230.16%	26.2%	11.28%	7.84%	3.49%	-	-	5.12%	-16.42%	15.74%	12.68%	14.45%	-36.91%	34.55%	3.49%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-8.766	-11.58	-9.529	-10.82	-11.75	-6.479	-9.896	-6.286	-	-8.102	-8.787	-8.215	-7.197	-7.262	-8.157	-9.421	-8.007	-7.238
Change	-	-32.1%	17.71%	-13.57%	-8.61%	44.88%	-52.74%	36.48%	-	-	-8.45%	6.51%	12.39%	-0.9%	-12.32%	-15.5%	15.01%	9.6%
Charge d'intérêts ¹	-	-2.009	-2.078	-2.433	-4.194	-2.536	-2.731	-2.634	-	-3.453	-0.5	-0.611	0.108	0.162	0.11	0.056	0.015	-0.006
Earnings before Tax (EBT) ¹	-12.01	-14.08	-12.19	-14.32	-18.16	-9.39	-12.61	-8.232	-	-12.29	-7.904	-9.368	-9.628	-10.02	-10.23	-10.6	-10.56	-9.648
Change	-	-17.25%	13.42%	-17.44%	-26.86%	48.3%	-34.28%	34.71%	-	-	35.69%	-18.52%	-2.78%	-4.08%	-2.13%	-3.54%	0.34%	8.64%
Net income ¹	-12.01	-14.08	-12.19	-14.31	-17.99	-9.367	-12.52	-7.581	-12.2	-12.15	-7.778	-9.226	-9.492	-9.854	-9.92	-10.46	-10.41	-9.502
Change	-	-17.25%	13.42%	-17.4%	-25.66%	47.92%	-33.66%	39.45%	-60.96%	0.43%	35.98%	-18.62%	-2.88%	-3.81%	-0.67%	-5.48%	0.54%	8.7%
Announcement Date	17/05/21	13/08/21	17/11/21	11/03/22	10/05/22	22/08/22	14/11/22	24/03/23	15/05/23	14/08/23	14/11/23	14/05/24	13/08/24	13/11/24	31/03/25	15/05/25	14/08/25	14/11/25

¹USD in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-	-	-	-	-	-2.75	-2.47
Change	-	-	-	-	-	-	10.18%
Announcement Date	11/03/22	24/03/23	01/04/24	31/03/25	07/04/26	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021	2022	2024	2026	2027
CAPEX ¹	0.006	0.077	0.016	0.1	0.15
Change	-	1,183.33%	-	-	50%
Free Cash Flow (FCF) ¹	-	-	-	2.015	-3.596
Change	-	-	-	-	-278.46%
Announcement Date	11/03/22	24/03/23	31/03/25	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-	-382.2%	20.31%	-4.15%
EBIT Margin (%)	-	-939.05%	-287.85%	-	-263.76%	-398.82%	11.06%	-17.55%
EBT Margin (%)	-	-1,213.38%	-404.78%	-	-335.79%	-469.09%	-11.9%	-43.06%
Net margin (%)	-	-1,213.26%	-396.91%	-	-329.3%	-465.42%	-9.17%	-39.09%
FCF margin (%)	-	-	-	-	-	-	9.85%	-25.48%
FCF / Net Income (%)	-	-	-	-	-	-	-107.41%	65.18%
Profitability
ROA	-33.6%	-50.82%	-42.71%	-43.17%	-36.99%	-61.46%	-	-
ROE	-179.03%	-362.07%	-922.07%	-2,366.62%	-565.74%	1,112.31%	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	0.14%	0.64%	-	0.14%	-	0.49%	1.06%
CAPEX / EBITDA (%)	-	-	-	-	-	-	2.41%	-25.6%
CAPEX / FCF (%)	-	-	-	-	-	-	4.96%	-4.17%
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	0.94	0.81
Change	-	-	-	-	-	-	-	-13.83%
EPS ¹	-	-1,32,750	-54,270	-2,685	-130.7	-22.97	-0.12	-0.27
Change	-	-	59.12%	95.05%	95.13%	82.42%	99.48%	-125%
Nbr of stocks (in thousands)	-	0.41	1.34	33.8	472	4,537	13,019	13,019
Announcement Date	-	11/03/22	24/03/23	01/04/24	31/03/25	07/04/26	-	-